These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8126253)

  • 1. Influence of application site of a new transdermal clonidine, M-5041T, on its pharmacokinetics and pharmacodynamics in healthy subjects.
    Ebihara A; Fujimura A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1188-91. PubMed ID: 8126253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of a new transdermal clonidine, M-5041T, in healthy subjects.
    Fujimura A; Ebihara A; Shiga T; Kumagai Y; Ohashi K; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1993 Dec; 33(12):1192-200. PubMed ID: 8126254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects.
    Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T
    J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of bathing and hot weather on the pharmacokinetics of a new transdermal clonidine, M-5041T.
    Fujimura A; Sasaki M; Harada K; Kumagai Y; Ohashi K; Ebihara A
    J Clin Pharmacol; 1996 Oct; 36(10):892-6. PubMed ID: 8930775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical assessment of a new transdermal delivery system for clonidine (M-5041T).
    Naruse T; Ishida T; Ishii R; Tagawa T
    Fundam Clin Pharmacol; 1996; 10(1):47-55. PubMed ID: 8900500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a newly developed transdermal clonidine delivery system (M-5041T) on EEG sleep-wake cycle in relation to plasma concentration in rabbits.
    Kimura K; Ishihara K; Tagawa T; Sakurai M; Fujii Y; Dote S; Naruse T; Sasa M; Namba K
    Gen Pharmacol; 1996 Jan; 27(1):73-7. PubMed ID: 8742497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin pretreatment and the use of transdermal clonidine.
    Ito MK; O'Connor DT
    Am J Med; 1991 Jul; 91(1A):42S-49S. PubMed ID: 1831005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of oral versus sublingual clonidine.
    Cunningham FE; Baughman VL; Peters J; Laurito CE
    J Clin Anesth; 1994; 6(5):430-3. PubMed ID: 7986518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of transdermally delivered clonidine.
    MacGregor TR; Matzek KM; Keirns JJ; van Wayjen RG; van den Ende A; van Tol RG
    Clin Pharmacol Ther; 1985 Sep; 38(3):278-84. PubMed ID: 4028622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine.
    Arndts D; Arndts K
    Eur J Clin Pharmacol; 1984; 26(1):79-85. PubMed ID: 6714294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Systemic and Local Pharmacokinetics of Clonidine Mucoadhesive Buccal Tablets with Reference Clonidine Oral Tablets in Healthy Volunteers: An Open-Label Randomised Cross-Over Trial.
    Vasseur B; Dufour A; Houdas L; Goodwin H; Harries K; Emul NY; Hutchings S
    Adv Ther; 2017 Aug; 34(8):2022-2032. PubMed ID: 28726169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring.
    Mancia G; Parati G; Pomidossi G; Malaspina D; Colombo A; Camesasca C; Groppelli A; Casadei R; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S187-93. PubMed ID: 2455177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose linearity of clonidine after transdermal application.
    Wallenstein G; Gladigau V
    Clin Auton Res; 1993 Dec; 3(6):369-72. PubMed ID: 8193523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.
    Shaw JE
    Am Heart J; 1984 Jul; 108(1):217-23. PubMed ID: 6428208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of clonidine as transdermal therapeutic system: the international clinical trial experience.
    Lowenthal DT; Saris S; Paran E; Cristal N; Sharif K; Bies C; Fagan T
    Am Heart J; 1986 Oct; 112(4):893-900. PubMed ID: 3532747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with transdermal clonidine in mild hypertension.
    Fillingim JM; Matzek KM; Hughes EM; Johnson PA; Sharon GS
    Clin Ther; 1989; 11(3):398-408. PubMed ID: 2743374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transdermal therapy of arterial hypertension: a new approach in the management of hypertensive patients].
    Ambrosioni E
    Ann Ital Med Int; 1994 Oct; 9 Suppl():54S-57S. PubMed ID: 7857759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.